Posted by: Audrey Erbes | July 21, 2013

Life Science VC Funding Up Plus Events This Coming Week

I’m back from my vacation refreshed and was pleased to find some great news in my mailbox. Quarter two VC funding for life science is up and medtech experienced the highest level of investments in startup companies in five quarters. “In total, the healthcare sector brought in $1.81 billion through 151 deals funded by venture capitalists. The money invested in the last quarter represents a 24% increase over the first quarter of the year when $1.47 billion was invested through 141 deals.” Source: “Q2 Venture Capital Investments in Early-Stage Healthcare Companies Reach Five-Quarter High,” MD&DI, July 16, 2013. 

Fierce Biotech reports a surge in biotech venture capital investments in the second quarter in the article “$1.3B VC cash surge buoys biotech as analysts point to a rebound” by John Carroll, July 18, 2013. Investments in first round financing was significantly up while also following 3 months of great IPO numbers.

But in an article covering medical devices Fierce Biotech is not so enthusiastic as MD&DI. They see a positive only in that a slight decline in medical device funding in this quarter is an improvement for the sector over first quarter declines. They attribute this situation to uncertainty of device insurance reimbursement which is scaring away investors. “Exits” for biotech are much clearer than for medtech. Source: “Med tech VC investing remains sluggish, biotech surges,” by Mark Hollmer, July 19, 2013.

I look forward to reading the Money Tree report to see how PWC and the National Venture Capital Association analyze the second quarter funding results.

If you are following the U.S. medical device industry prospects, be sure to attend this week’s Bio2Device Group morning meeting and hear a worldwide regulatory expert Dr. Martine Dehlinger-Kremer, Global Vice President, Regulatory Affairs RPS Research Pharmaceutical Services discuss changing European medical device regulations. The meeting is open to the public and free. See details in list of Audrey’s Picks downloadable from this site or my blog at www.AudreysNetwork.com.

Highlights for Events This Coming Week

  • BioCentury This Week, See new program Webcast Starting Sunday, July 21, 2013 http://www.biocenturytv.com, Available anytime starting at 9:00 a.m. EDT; Topic: “ACA Speed Bumps?: Front Line Reports,” with speakers Dr. Joshua Sharfstein, former Obama appointee to FDA and now Secretary of Health and Mental Hygiene of Maryland; William Dennis of the National Federation of Independent Business
  • Bio2Device Group, Tuesday Morning, July 23, 2013; Topic: “Changing Medical Device Regulations in Europe;” Speaker: Dr. Martine Dehlinger-Kremer, Global Vice President, Regulatory Affairs RPS Research Pharmaceutical Services; Date and Time: Tuesday, July 23, 2013, 8:30 – 10:30 am; Location: Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA; Cost: No charge; No registration required
  • HBA San Francisco Bay Area, Wednesday Evening, July 24, 2013; Topic:  “Review of Lean In by Sheryl Sandberg; Speaker: Kimberly Farrell, CEO, Unlimited Performance Training, Inc.
  • BioScience Forum, Wednesday Evening, July 24, 2013; Topic: “Non-invasive Prenatal Testing: A New Era for Fetal Trisomy Detection;” Speaker: Thomas Musci, M.D., Vice President, Clinical and Medical Affairs, Ariosa
  • ASQ, Wednesday Evening, July 24, 2013; Topic: “Achieving Compliance with IEC 62304 for Development of Medical Device Software;” Speaker: Tim Stein, Founder, Business Performance Associates, Inc.; Moderator: Thi Nguyen, Quality Engineer at Velomedix, CQE, CSQE
  • WIB, San Francisco Bay Area, Thursday Evening, July 25, 2013; Event: “WIB-San Francisco Bay Area “Summer in the City” Networking Happy Hour”
  • RAPS, Friday, July 26, 2023; Event: 2013 FDA Pacific Region Update and Case for Quality Forum; Speakers: Jan Welch, deputy director for regulatory affairs, CDRH, US FDA; William (Bill) MacFarland, director, Division of Enforcement B, CDRH, US FDA; Eugene Reily, Division of Risk Management Operations, CDRH, US FDA; Mark Roh, regional food and drug director, Pacific Region US FDA; Judy Stojny, deputy regional food and drug director, Pacific Region US FDA; Donna Godward, chief quality officer, MD&D, Johnson & Johnson
  • CBA, Saturday, July 27, 2013; Event:  Annual Picnic

You can download the complete list of events with all the details from Audreys picks July 21, 2013 by right clicking the highlighted title. I’ll be publishing a new listing of Jobs that Crossed My Desk early this week. I chose to take a real vacation so haven’t prepared list of those crossing my desk during my absence. I will be providing new job listings received since June 15th. Stay tuned.

Audrey

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: